Payout • Atrium Therapeutics
RNA
Atrium Therapeutics Inc. is a clinical-stage biopharmaceutical company pioneering the development of atrial-selective gene therapies for the treatment of atrial fibrillation (AFib), the most prevalent sustained cardiac arrhythmia worldwide. The company's mission is to provide a durable, one-time treatment that restores and maintains normal sinus rhythm, addressing the limitations of current standard-of-care treatments such as anti-arrhythmic drugs and catheter ablation. Atrium's proprietary platform focuses on localized delivery of genetic material to the heart's atria. Its lead product candidate, ATR-101, is an investigational gene therapy designed to be delivered via a single administration to the epicardial surface of the atria during a minimally invasive procedure or concomitant with cardiac surgery. ATR-101 works by expressing a modified potassium channel that prolongs the atrial refractory period, thereby suppressing the electrical triggers and substrates that sustain AFib. By targeting the underlying electrophysiological mechanisms of the disease specifically within the atrial tissue, Atrium Therapeutics aims to minimize systemic side effects and improve long-term outcomes for patients suffering from paroxysmal or persistent AFib. The company is positioned at the intersection of cardiovascular medicine and advanced genetic therapeutics, seeking to fill a significant unmet need in the management of chronic heart rhythm disorders.
0
Dividend Per Share
The sum of declared dividends issued by a company for every ordinary share outstanding.
0%
Dividend Yield
Dividend Yield is a financial ratio that shows how much a company pays out in dividends each year relative to its share price in the last twelve months. In the absence of any capital gains, the dividend yield is the return on investment for a stock.
-7,9%
Buyback Yield
It is another way that companies have to remunerate their shareholders, being an alternative to dividends. Shows the % of repurchases per share made in the last 12 months in relation to the share price.
-7,9%
Total Yield
Sum of Dividend Yield and BuyBack Yield to show the total return that the shareholder received in the last 12 months in relation to the share price.
0%
Payout
The dividend payout ratio is the ratio of the total amount of dividends paid out to shareholders relative to the net income of the company. It is the percentage of earnings paid to shareholders via dividends.
-62,7M
Retained Earnings
Retained earnings (RE) are the amount of net income left over for the business after it has paid out dividends to its shareholders and are an important variable for assessing a company's financial health because it shows the net income that a company has saved over time, and therefore has the ability to reinvest in the business or distribute to shareholders.
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!